Inventor · disambiguated record
Hans-Michael Wolff
Also filed as: WOLFF HANS M · WOLFF HANS-MICHAEL
29 granted patents·8 pending applications·564 citations·filing 1992–2022
97Inventor score
Files withSANOL ARZNEI SCHWARZ GMBH12UCB PHARMA GMBH6WOLFF HANS-MICHAEL5LTS LOHMANN THERAPIE SYSTEME AG4SCHACHT DIETRICH WILHELM3
Top patents by PatentIndex Score
37 records- 0193US8617591B2Transdermal delivery system for the administration of rotigotineSCHACHT DIETRICH WILHELM·Filed 2012·Granted Dec 31, 2013·31 cites·30 claims
- 0293US6783769B1Transdermal therapeutic system TTS containing tolterodineSANOL ARZNEI SCHWARZ GMBH·Filed 2000·Granted Aug 31, 2004·55 cites·7 claims
- 0392US5393529AEstrogen-containing active substance plasterLOHMANN THERAPIE SYST LTS·Filed 1993·Granted Feb 28, 1995·148 cites·8 claims
- 0484US6461636B1Transdermal therapeutic system containing pergolideSANOL ARZNEI SCHWARZ GMBH·Filed 1999·Granted Oct 8, 2002·72 cites·8 claims
- 0583US6555131B1Therapeutical system for transdermal delivery of levonorgestrelSANOL ARZNEI SCHWARZ GMBH·Filed 1998·Granted Apr 29, 2003·60 cites·15 claims
- 0682US6562367B1Transdermal therapeutic system (TTS) for administering sexual steroid hormonesSANOL ARZNEI SCHWARZ GMBH·Filed 1998·Granted May 13, 2003·55 cites·12 claims
- 0781US8211462B2Hot-melt TTS for administering rotigotineBREITENBACH ARMIN·Filed 2004·Granted Jul 3, 2012·14 cites·25 claims
- 0879US8246979B2Transdermal delivery system for the administration of rotigotineSCHACHT DIETRICH WILHELM·Filed 2003·Granted Aug 21, 2012·11 cites·18 claims
- 0978US10350174B2Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotineUCB PHARMA GMBH·Filed 2018·Granted Jul 16, 2019·1 cites·16 claims
- 1077US9034914B2Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresisUCB PHARMA GMBH·Filed 2014·Granted May 19, 2015·2 cites·12 claims
- 1176US8592477B2Polymorphic form of rotigotine and process for productionWOLFF HANS-MICHAEL·Filed 2008·Granted Nov 26, 2013·3 cites·5 claims
- 1276US8232414B2Polymorphic form of rotigotine and process for productionWOLFF HANS-MICHAEL·Filed 2008·Granted Jul 31, 2012·3 cites·3 claims
- 1375US9925150B2Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotineWOLFF HANS MICHAEL·Filed 2010·Granted Mar 27, 2018·2 cites·25 claims
- 1473US5527536AActive ingredient patch for low-melting and/or volatile active ingredientsSANOL ARZNEI SCHWARZ GMBH·Filed 1993·Granted Jun 18, 1996·43 cites·16 claims
- 1569US12070521B2Method for adjusting the release of active agent in a transdermal delivery systemLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Granted Aug 27, 2024·0 cites·10 claims
- 1669US8754120B2Pharmaceutical composition comprising rotigotine salts (acid or Na), especially for iontophoresisBOUWSTRA JOHANNA AALTJE·Filed 2010·Granted Jun 17, 2014·4 cites·7 claims
- 1769US7989654B2High purity bases of 3,3-diphenylpropylamino monoestersUCB PHARMA GMBH·Filed 2008·Granted Aug 2, 2011·0 cites·16 claims
- 1869US7670621B2Transdermal administration of (R)-3,3-diphenylpropylamin-monoestersSANOL ARZNEI SCHWARZ GMBH·Filed 2004·Granted Mar 2, 2010·2 cites·16 claims
- 1968US5498418ANitroglycerine plaster and process for its productionSANOL ARZNEI SCHWARZ GMBH·Filed 1992·Granted Mar 12, 1996·26 cites·6 claims
- 2066US8246980B2Transdermal delivery systemSCHACHT DIETRICH WILHELM·Filed 2003·Granted Aug 21, 2012·1 cites·17 claims
- 2166US7632859B2Iontophoretic delivery of rotigotine for the treatment of Parkinson's diseaseSANOL ARZNEI SCHWARZ GMBH·Filed 2003·Granted Dec 15, 2009·7 cites·12 claims
- 2264US10130589B2Polyvinylpyrrolidone for the stabilization of a solid dispersion of the non-crystalline form of rotigotineUCB PHARMA GMBH·Filed 2018·Granted Nov 20, 2018·0 cites·24 claims
- 2362US2022151949A1Multi-Day Patch for the Transdermal Administration of RotigotineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2022·Application pending·0 cites
- 2462US2019314294A1Polyvinylpyrrolidone For The Stabilization Of A Solid Dispersion Of The Non-Crystalline Form Of RotigotineUCB PHARMA GMBH·Filed 2019·Application pending·0 cites
- 2561US7919117B2Transdermal delivery of (R)-3,3-diphenylpropylamin-monoesternUCB PHARMA GMBH·Filed 2009·Granted Apr 5, 2011·0 cites·24 claims
- 2658US11389410B2Multi-day patch for the transdermal administration of rotigotineLTS LOHMANN THERAPIE SYSTEME AG·Filed 2013·Granted Jul 19, 2022·0 cites·27 claims
- 2758US2006014832A1Highly pure bases of 3,3-dipheyl propylamine monoestersSANOL ARZNEI SCHWARZ GMBH·Filed 2004·Application pending·0 cites
- 2853US11426359B2Method for adjusting the release of active agent in a transdermal delivery systemLTS LOHMANN THERAPIE SYSTEME AG·Filed 2015·Granted Aug 30, 2022·0 cites·14 claims
- 2951US2006216336A1Transdermal therapeutic system for Parkinson's DiseaseWOLFF HANS-MICHAEL·Filed 2005·Application pending·0 cites
- 3051US2006263419A1Transdermal therapeutic system for Parkinson's DiseaseWOLFF HANS-MICHAEL·Filed 2005·Application pending·0 cites
- 3149US2003026830A1Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotineFiled 2002·Application pending·0 cites
- 3249US2003027793A1Transdermal treatment of parkinson's diseaseFiled 2002·Application pending·0 cites
- 3345US5603948AActive ingredient patch for low-melting and/or volatile active ingredientsSANOL ARZNEI SCHWARZ GMBH·Filed 1995·Granted Feb 18, 1997·9 cites·5 claims
- 3443US9186335B2Hot melt TTS for administering rotigotineBREITENBACH ARMIN·Filed 2003·Granted Nov 17, 2015·0 cites·22 claims
- 3541US2005226919A1Device for transdermal administration for the treatment of urinary tract disordersDRESSEN FRANK·Filed 2002·Application pending·0 cites
- 3637US6555129B1Transdermal therapeutic system (TTS) containing oxybutyninSANOL ARZNEI SCHWARZ GMBH·Filed 1999·Granted Apr 29, 2003·14 cites·12 claims
- 3727US5817697ATransdermal presentation of nitroglycerin for preventing undesired laborSANOL ARZNEI SCHWARZ GMBH·Filed 1995·Granted Oct 6, 1998·1 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Hans-Michael Wolff files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →